Latest Articles

Publication Date
Dose-Response And Threshold Effects of a C-reactive Protein-Triglyceride-Glucose Composite Index and Endometriosis Risk: A Cross-Sectional Study.

Endometriosis is a prevalent gynecological disorder associated with chronic low-grade inflammation, yet diagnosis is often delayed because symptoms are non-specific and definitive confirmation typically relies on invasive procedures. Composite indices …

Published: March 10, 2026, midnight
Development of an early prediction model for endometriosis risk: the simplified adolescent factors for endometriosis (SAFE) score.

Endometriosis affects 11% of women of reproductive age. Diagnosis is often delayed by 6-8 years due to nonspecific symptoms and lack of early detection tools. This study aimed to develop …

Published: March 9, 2026, midnight
Are your sanitary pads safe? Uncovering the risks of harmful chemicals - IOL

Are your sanitary pads safe? Uncovering the risks of harmful chemicals IOL

Published: March 8, 2026, 4:51 p.m.
Breast Cancer Patients Choosing Alternative Medicine Face Higher Death Risk | Women's Day - Health and Me

Breast Cancer Patients Choosing Alternative Medicine Face Higher Death Risk | Women's Day Health and Me

Published: March 8, 2026, 12:46 p.m.
From lipid profiles to disease onset: Triglycerides as predictive biomarkers in endometriosis.

Dyslipidaemia is related to endometriosis, but it is not known which lipid component is most relevant, and whether the observed correlation reflects the causal relationship. The relationship between triglycerides (TG) …

Published: March 7, 2026, midnight
Effects of E2/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis.

Patients with endometriosis have greater risk of infertility, which is associated with compromised ovarian function. Dysfunction in follicular granulosa cells and hyperactivation of oestrogen receptor beta (ERβ) are evident in …

Published: March 6, 2026, midnight
Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence - The ASCO Post

Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence The ASCO Post

Published: March 5, 2026, 4:20 p.m.
Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence - Contemporary OB/GYN

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence Contemporary OB/GYN

Published: March 5, 2026, 12:23 a.m.
Lactoferrin as a Non-Hormonal Therapeutic Candidate for Endometriosis: Mechanisms and Future Directions.

The pathogenesis and progression of endometriosis may involve a complex combination of multiple factors, including chronic inflammation and oxidative stress. Hormonal therapy, the current standard for pharmacotherapy in endometriosis, causes …

Published: March 5, 2026, midnight
The silent risk after IVF: What women with endometriosis must know - The Times of India

The silent risk after IVF: What women with endometriosis must know The Times of India

Published: March 4, 2026, 5:47 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!